本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Achilles Therapeutics plc

1.48
0.0000
成交量:- -
成交額:- -
市值:6,302.59萬
市盈率:-0.89
高:1.48
開:1.48
低:1.48
收:1.48
52周最高:1.51
52周最低:0.9601
股本:4,258.51萬
流通股本:2,084.76萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.6590
每股收益(LYR):-1.7428
淨資產收益率:-52.12%
總資產收益率:-30.17%
市淨率:0.61
市盈率(LYR):-0.85

資料載入中...

2025/03/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/11

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/25

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/04/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]